| Year |
Citation |
Score |
| 2022 |
Nahar L, Kaufman SE, Davis PG, Saunders SL, Disbrow EA, Patterson JC, Nam HW. Blood glutamine synthetase signaling in alcohol use disorder and racial disparity. Translational Psychiatry. 12: 71. PMID 35194024 DOI: 10.1038/s41398-022-01837-w |
0.597 |
|
| 2021 |
Nahar L, Delacroix BM, Nam HW. The Role of Parvalbumin Interneurons in Neurotransmitter Balance and Neurological Disease. Frontiers in Psychiatry. 12: 679960. PMID 34220586 DOI: 10.3389/fpsyt.2021.679960 |
0.559 |
|
| 2020 |
Nahar L, Grant CA, Hewett C, Cortes D, Reker AN, Kang S, Choi DS, Nam HW. Regulation of Pv-Specific Interneurons in the Medial Prefrontal Cortex and Reward-Seeking Behaviors. Journal of Neurochemistry. PMID 32594517 DOI: 10.1111/jnc.15106 |
0.69 |
|
| 2019 |
Nam HW, Grant C, Jorgensen A, Heppelmann CJ, Trutschl M, Cvek U. Neurogranin Regulates Alcohol Sensitivity Through AKT Pathway in the Nucleus Accumbens. Proteomics. e1900266. PMID 31814311 DOI: 10.1002/Pmic.201900266 |
0.482 |
|
| 2019 |
Sullivan JM, Grant C, Reker AN, Nahar L, Goeders NE, Nam HW. Neurogranin regulates sensorimotor gating through cortico-striatal circuitry. Neuropharmacology. PMID 30902751 DOI: 10.1016/j.neuropharm.2019.03.021 |
0.598 |
|
| 2018 |
Germany CE, Reker AN, Hinton DJ, Oliveros A, Shen X, Andres-Beck LG, Wininger KM, Trutchul M, Cvek U, Choi DS, Nam HW. Pharmacoproteomics Profile in Response to Acamprosate Treatment of an Alcoholism Animal Model. Proteomics. PMID 29437267 DOI: 10.1002/Pmic.201700417 |
0.614 |
|
| 2018 |
Germany CE, Reker AN, Hinton DJ, Oliveros A, Shen X, Andres-Beck LG, Wininger KM, Trutschl M, Cvek U, Choi D, Nam HW. Front Cover: Pharmacoproteomics Profile in Response to Acamprosate Treatment of an Alcoholism Animal Model Proteomics. 18: 1870051. DOI: 10.1002/Pmic.201870051 |
0.513 |
|
| 2017 |
Reker AN, Oliveros A, Sullivan JM, Nahar L, Hinton DJ, Kim T, Bruner RC, Choi DS, Goeders NE, Nam HW. Neurogranin in the nucleus accumbens regulates NMDA receptor tolerance and motivation for ethanol seeking. Neuropharmacology. 131: 58-67. PMID 29225043 DOI: 10.1016/j.neuropharm.2017.12.008 |
0.735 |
|
| 2015 |
Nam HW, Karpyak VM, Hinton DJ, Geske JR, Ho AM, Prieto ML, Biernacka JM, Frye MA, Weinshilboum RM, Choi DS. Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects. Translational Psychiatry. 5: e621. PMID 26285131 DOI: 10.1038/tp.2015.120 |
0.393 |
|
| 2013 |
Nam HW, Bruner RC, Choi DS. Adenosine signaling in striatal circuits and alcohol use disorders. Molecules and Cells. 36: 195-202. PMID 23912595 DOI: 10.1007/s10059-013-0192-9 |
0.681 |
|
| 2013 |
Nam HW, Hinton DJ, Kang NY, Kim T, Lee MR, Oliveros A, Adams C, Ruby CL, Choi DS. Adenosine transporter ENT1 regulates the acquisition of goal-directed behavior and ethanol drinking through A2A receptor in the dorsomedial striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 4329-38. PMID 23467349 DOI: 10.1523/Jneurosci.3094-12.2013 |
0.719 |
|
| 2013 |
Choi D, Nam H, Karpyak V. PP135—Pharmacometabolomics for individualized treatment of alcoholism: High serum glutamate level is associated with positive response to acamprosate treatment Clinical Therapeutics. 35: e58. DOI: 10.1016/J.CLINTHERA.2013.07.157 |
0.314 |
|
| 2012 |
Nam HW, McIver SR, Hinton DJ, Thakkar MM, Sari Y, Parkinson FE, Haydon PG, Choi DS. Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders. Alcoholism, Clinical and Experimental Research. 36: 1117-25. PMID 22309182 DOI: 10.1111/J.1530-0277.2011.01722.X |
0.581 |
|
| 2011 |
Nam HW, Lee MR, Zhu Y, Wu J, Hinton DJ, Choi S, Kim T, Hammack N, Yin JC, Choi DS. Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-D-aspartate receptor signaling. Biological Psychiatry. 69: 1043-51. PMID 21489406 DOI: 10.1016/J.Biopsych.2011.02.013 |
0.711 |
|
| 2011 |
Kim JH, Karpyak VM, Biernacka JM, Nam HW, Lee MR, Preuss UW, Zill P, Yoon G, Colby C, Mrazek DA, Choi DS. Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures. Plos One. 6: e16331. PMID 21283641 DOI: 10.1371/Journal.Pone.0016331 |
0.666 |
|
| 2011 |
Asatryan L, Nam HW, Lee MR, Thakkar MM, Saeed Dar M, Davies DL, Choi DS. Implication of the purinergic system in alcohol use disorders. Alcoholism, Clinical and Experimental Research. 35: 584-94. PMID 21223299 DOI: 10.1111/J.1530-0277.2010.01379.X |
0.706 |
|
| 2010 |
Ruby CL, Adams CA, Knight EJ, Nam HW, Choi DS. An essential role for adenosine signaling in alcohol abuse. Current Drug Abuse Reviews. 3: 163-74. PMID 21054262 DOI: 10.2174/1874473711003030163 |
0.661 |
|
| 2010 |
Nam HW, Lee MR, Hinton DJ, Choi DS. Reduced effect of NMDA glutamate receptor antagonist on ethanol-induced ataxia and striatal glutamate levels in mice lacking ENT1. Neuroscience Letters. 479: 277-81. PMID 20570605 DOI: 10.1016/J.Neulet.2010.05.079 |
0.724 |
|
| 2010 |
Chen J, Nam HW, Lee MR, Hinton DJ, Choi S, Kim T, Kawamura T, Janak PH, Choi DS. Altered glutamatergic neurotransmission in the striatum regulates ethanol sensitivity and intake in mice lacking ENT1. Behavioural Brain Research. 208: 636-42. PMID 20085785 DOI: 10.1016/J.Bbr.2010.01.011 |
0.723 |
|
| Show low-probability matches. |